Drugs Made In America Acquisition Corp. (NASDAQ: DMAAU) Successfully Completes $200 Million IPOFort Lauderdale, FL, Jan. 29, 2025 – Drugs Made In America Acquisition Corp. (NASDAQ: DMAAU) recently announced the successful closure of its initial publi

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Drugs Made in America Acquisition’s 8K filing here.

Drugs Made in America Acquisition Company Profile

Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.